Medpace Holdings Total Current Assets 2014-2025 | MEDP
Medpace Holdings total current assets from 2014 to 2025. Total current assets can be defined as the sum of all assets that are classified as current because they will provide a benefit within one year.
- Medpace Holdings total current assets for the quarter ending March 31, 2025 were $0.821B, a 10.27% increase year-over-year.
- Medpace Holdings total current assets for 2024 were $1.029B, a 73.32% increase from 2023.
- Medpace Holdings total current assets for 2023 were $0.594B, a 77.81% increase from 2022.
- Medpace Holdings total current assets for 2022 were $0.334B, a 51.66% decline from 2021.
| Medpace Holdings Annual Total Current Assets (Millions of US $) |
|
|---|---|
| 2024 | $1,029 |
| 2023 | $594 |
| 2022 | $334 |
| 2021 | $691 |
| 2020 | $474 |
| 2019 | $317 |
| 2018 | $178 |
| 2017 | $130 |
| 2016 | $133 |
| 2015 | $95 |
| 2014 | $133 |
| 2013 | $0 |
| Medpace Holdings Quarterly Total Current Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $821 |
| 2024-12-31 | $1,029 |
| 2024-09-30 | $1,033 |
| 2024-06-30 | $873 |
| 2024-03-31 | $745 |
| 2023-12-31 | $594 |
| 2023-09-30 | $449 |
| 2023-06-30 | $379 |
| 2023-03-31 | $368 |
| 2022-12-31 | $334 |
| 2022-09-30 | $338 |
| 2022-06-30 | $329 |
| 2022-03-31 | $356 |
| 2021-12-31 | $691 |
| 2021-09-30 | $641 |
| 2021-06-30 | $550 |
| 2021-03-31 | $533 |
| 2020-12-31 | $474 |
| 2020-09-30 | $395 |
| 2020-06-30 | $319 |
| 2020-03-31 | $303 |
| 2019-12-31 | $317 |
| 2019-09-30 | $250 |
| 2019-06-30 | $194 |
| 2019-03-31 | $182 |
| 2018-12-31 | $178 |
| 2018-09-30 | $153 |
| 2018-06-30 | $158 |
| 2018-03-31 | $154 |
| 2017-12-31 | $130 |
| 2017-09-30 | $117 |
| 2017-06-30 | $123 |
| 2017-03-31 | $128 |
| 2016-12-31 | $133 |
| 2016-09-30 | $121 |
| 2016-06-30 | |
| 2016-03-31 | |
| 2015-12-31 | |
| 2015-09-30 | |
| 2014-12-31 | $133 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $8.792B | $2.109B |
| Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization which provides Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace Holdings, Inc. is headquartered in Cincinnati, Ohio. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.009B | 27.20 |
| Elevance Health (ELV) | United States | $86.741B | 11.19 |
| CVS Health (CVS) | United States | $81.290B | 10.10 |
| Cencora (COR) | United States | $55.092B | 19.17 |
| DiDi Global (DIDIY) | China | $23.485B | 35.64 |
| Natera (NTRA) | United States | $22.560B | 0.00 |
| BioMerieux (BMXMF) | France | $16.856B | 0.00 |
| Solventum (SOLV) | United States | $13.071B | 13.84 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.026B | 0.00 |
| ICON (ICLR) | Ireland | $11.688B | 10.87 |
| Revvity (RVTY) | United States | $11.345B | 19.52 |
| CochLear (CHEOY) | Australia | $11.134B | 0.00 |
| Doximity (DOCS) | United States | $10.995B | 50.90 |
| Viatris (VTRS) | United States | $10.610B | 3.65 |
| Avantor (AVTR) | United States | $9.329B | 13.55 |
| HealthEquity (HQY) | United States | $9.272B | 40.61 |
| Sonic Healthcare (SKHHY) | Australia | $8.450B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.416B | 14.53 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.450B | 26.21 |
| BrightSpring Health Services (BTSG) | United States | $3.875B | 35.87 |
| Sotera Health (SHC) | United States | $3.491B | 19.84 |
| Surgery Partners (SGRY) | United States | $2.989B | 38.87 |
| Alignment Healthcare (ALHC) | United States | $2.898B | 0.00 |
| Concentras Parent (CON) | United States | $2.816B | 16.27 |
| Organon (OGN) | United States | $2.610B | 2.77 |
| GeneDx Holdings (WGS) | United States | $1.983B | 76.39 |
| Progyny (PGNY) | United States | $1.923B | 42.32 |
| Ardent Health Partners (ARDT) | United States | $1.920B | 8.18 |
| Premier (PINC) | United States | $1.884B | 14.30 |
| PACS (PACS) | United States | $1.629B | 0.00 |
| GoodRx Holdings (GDRX) | United States | $1.622B | 32.43 |
| Teladoc Health (TDOC) | United States | $1.298B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.213B | 9.23 |
| Establishment Labs Holdings (ESTA) | $1.124B | 0.00 | |
| CareDx (CDNA) | United States | $1.105B | 17.26 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.944B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.843B | 7.89 |
| QDM (QDMI) | Hong Kong, SAR China | $0.752B | 0.00 |
| Nutex Health (NUTX) | United States | $0.651B | 9.85 |
| Embecta (EMBC) | United States | $0.592B | 3.99 |
| LifeMD (LFMD) | United States | $0.553B | 0.00 |
| Enhabit (EHAB) | United States | $0.543B | 44.67 |
| InnovAge Holding (INNV) | United States | $0.514B | 0.00 |
| SBC Medicals (SBC) | United States | $0.495B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.470B | 10.58 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.445B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.258B | 0.00 |
| Oncology Institute (TOI) | United States | $0.237B | 0.00 |
| Beauty Health (SKIN) | United States | $0.202B | 0.00 |
| DocGo (DCGO) | United States | $0.156B | 25.50 |
| KindlyMD (KDLY) | United States | $0.150B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.104B | 0.00 |
| So-Young (SY) | China | $0.090B | 0.00 |
| OncoCyte (OCX) | United States | $0.079B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.075B | 0.00 |
| KindlyMD (NAKA) | United States | $0.070B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.060B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.057B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.056B | 0.00 |
| Biodesix (BDSX) | United States | $0.048B | 0.00 |
| ModivCare (MODV) | United States | $0.047B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.029B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.013B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.006B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| INVO Fertility (IVF) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |